EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endocrine and Metabolic Modulation of Vascular Dysfunction in the Diabetic Foot: A Narrative Review

Luca Galassi, Erica Altamura, Elena Goldoni, Gabriele Carioti, Beatrice Faitelli, Matteo Lino Ravini, Niccolò Le Donne, Kristi Nika

Endocrines · 25.01.2026 · 7 (1) · 4

DOI: 10.3390/endocrines7010004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrines, online erschienen am 25.01.2026. Verfasst von Luca Galassi und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot complications represent a major global health burden and arise from a multifactorial interaction between neuropathy, ischemia, infection, and impaired wound repair. Increasing evidence suggests that, beyond traditional vascular and metabolic risk factors, endocrine dysregulation plays a central role in shaping vascular dysfunction and tissue vulnerability in patients with diabetes. This narrative review provides an updated overview of the endocrine–vascular axis in the development, progression, and healing of diabetic foot ulcers (DFUs), integrating evidence from experimental and clinical studies identified through targeted searches of PubMed, Embase, and Scopus. We examine how alterations in insulin signaling, relative glucagon excess, adipokine imbalance, dysregulation of stress hormones, and thyroid dysfunction interact with chronic hyperglycemia, dyslipidemia, mitochondrial dysfunction, and low-grade inflammation to impair endothelial homeostasis. These disturbances promote oxidative stress, reduce nitric oxide bioavailability, and compromise microvascular perfusion, thereby creating a pro-ischemic and pro-inflammatory tissue environment that limits angiogenesis, extracellular matrix (ECM) remodeling, immune coordination, and effective wound repair. By linking pathophysiological mechanisms to clinical relevance, this review highlights potential biomarkers of endocrine–vascular dysfunction, implications for risk stratification, and emerging therapeutic perspectives targeting metabolic optimization, endothelial protection, and hormonal modulation. Finally, key knowledge gaps and priority areas for future translational and clinical research are discussed, supporting the development of integrated endocrine-based strategies aimed at improving DFU prevention, healing outcomes, and long-term limb preservation in patients with diabetes.

Zitieren

APA

Galassi, L., Altamura, E., Goldoni, E., Carioti, G., Faitelli, B., Ravini, M. L., Donne, N. L., & Nika, K. (2026). Endocrine and Metabolic Modulation of Vascular Dysfunction in the Diabetic Foot: A Narrative Review. Endocrines, 7(1), 4. https://doi.org/10.3390/endocrines7010004

Vancouver

Galassi L, Altamura E, Goldoni E, Carioti G, Faitelli B, Ravini ML, et al. Endocrine and Metabolic Modulation of Vascular Dysfunction in the Diabetic Foot: A Narrative Review. Endocrines. 2026;7(1):4. doi:10.3390/endocrines7010004

BibTeX
@article{Galassi2026,
  author = {Galassi, Luca and Altamura, Erica and Goldoni, Elena and Carioti, Gabriele and Faitelli, Beatrice and Ravini, Matteo Lino and Donne, Niccolò Le and Nika, Kristi},
  title = {Endocrine and Metabolic Modulation of Vascular Dysfunction in the Diabetic Foot: A Narrative Review},
  journal = {Endocrines},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {4},
  doi = {10.3390/endocrines7010004}
}
Kostenlos starten →